457 related articles for article (PubMed ID: 27111141)
1. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Swamy M; Pathak S; Grzes KM; Damerow S; Sinclair LV; van Aalten DM; Cantrell DA
Nat Immunol; 2016 Jun; 17(6):712-20. PubMed ID: 27111141
[TBL] [Abstract][Full Text] [Related]
2. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
3. Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome.
Ogawa M; Sawaguchi S; Kawai T; Nadano D; Matsuda T; Yagi H; Kato K; Furukawa K; Okajima T
J Biol Chem; 2015 Jan; 290(4):2137-49. PubMed ID: 25488668
[TBL] [Abstract][Full Text] [Related]
4. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
5. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways.
Ryczko MC; Pawling J; Chen R; Abdel Rahman AM; Yau K; Copeland JK; Zhang C; Surendra A; Guttman DS; Figeys D; Dennis JW
Sci Rep; 2016 Mar; 6():23043. PubMed ID: 26972830
[TBL] [Abstract][Full Text] [Related]
7. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J; Marchase RB; Chatham JC
J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
[TBL] [Abstract][Full Text] [Related]
8. Glutamine Links Obesity to Inflammation in Human White Adipose Tissue.
Petrus P; Lecoutre S; Dollet L; Wiel C; Sulen A; Gao H; Tavira B; Laurencikiene J; Rooyackers O; Checa A; Douagi I; Wheelock CE; Arner P; McCarthy M; Bergo MO; Edgar L; Choudhury RP; Aouadi M; Krook A; Rydén M
Cell Metab; 2020 Feb; 31(2):375-390.e11. PubMed ID: 31866443
[TBL] [Abstract][Full Text] [Related]
9. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
10. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
[TBL] [Abstract][Full Text] [Related]
11. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity.
Li T; Li X; Attri KS; Liu C; Li L; Herring LE; Asara JM; Lei YL; Singh PK; Gao C; Wen H
Cell Host Microbe; 2018 Dec; 24(6):791-803.e6. PubMed ID: 30543776
[TBL] [Abstract][Full Text] [Related]
13. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells.
Lund PJ; Elias JE; Davis MM
J Immunol; 2016 Oct; 197(8):3086-3098. PubMed ID: 27655845
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.
Kang JG; Park SY; Ji S; Jang I; Park S; Kim HS; Kim SM; Yook JI; Park YI; Roth J; Cho JW
J Biol Chem; 2009 Dec; 284(50):34777-84. PubMed ID: 19833729
[TBL] [Abstract][Full Text] [Related]
15. Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis.
Grigorian A; Lee SU; Tian W; Chen IJ; Gao G; Mendelsohn R; Dennis JW; Demetriou M
J Biol Chem; 2007 Jul; 282(27):20027-35. PubMed ID: 17488719
[TBL] [Abstract][Full Text] [Related]
16. Intracellular glycosylation and development.
O'Donnell N
Biochim Biophys Acta; 2002 Dec; 1573(3):336-45. PubMed ID: 12417416
[TBL] [Abstract][Full Text] [Related]
17. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
18. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
19. O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1.
Sakaidani Y; Ichiyanagi N; Saito C; Nomura T; Ito M; Nishio Y; Nadano D; Matsuda T; Furukawa K; Okajima T
Biochem Biophys Res Commun; 2012 Mar; 419(1):14-9. PubMed ID: 22310717
[TBL] [Abstract][Full Text] [Related]
20. Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells.
Donadio AC; Lobo C; Tosina M; de la Rosa V; Martín-Rufián M; Campos-Sandoval JA; Matés JM; Márquez J; Alonso FJ; Segura JA
J Cell Biochem; 2008 Feb; 103(3):800-11. PubMed ID: 17614351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
